开立医疗 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	2.0B	2.1B	1.8B	1.4B	1.2B
Revenue Growth %	-5.0%	20.2%	22.0%	24.2%	--
Total Revenue	2.0B	2.1B	1.8B	1.4B	1.2B
Cost Of Revenue	729.0M	685.0M	584.0M	471.0M	390.0M
+Gross Profit	1.3B	1.4B	1.2B	974.0M	773.0M
Gross Margin %	63.8%	67.7%	66.9%	67.4%	66.5%
Total Operating Cost	2.0B	1.7B	1.5B	1.3B	1.3B
Selling Expenses	573.0M	488.0M	423.0M	367.0M	324.0M
Admin Expenses	137.0M	128.0M	98.0M	90.8M	75.2M
Rd Expenses	473.0M	384.0M	329.0M	263.0M	237.0M
Finance Expenses	-37.4M	-44.7M	-29.9M	9.1M	31.8M
+Operating Income	122.0M	475.0M	382.0M	216.0M	-44.2M
Operating Margin %	6.1%	22.4%	21.7%	14.9%	-3.8%
Non Operating Income	255,300	218,600	109,400	40.0M	129,100
Non Operating Expenses	1.6M	1.2M	595,300	1.5M	495,500
Investment Income	602,700	-12.7M	9.3M	11.8M	24.1M
Fair Value Change Income	3.6M	-175,500	-3.9M	3.2M	3.5M
Asset Disposal Income	49,500	20,400	-744,300	-191,200	--
Asset Impairment Loss	113.0M	51.1M	40.1M	98.9M	232.0M
Other Income	115.0M	98.1M	94.7M	77.7M	77.0M
Income Before Tax	120.0M	474.0M	382.0M	254.0M	-44.5M
Income Tax	-22.2M	19.4M	12.1M	7.0M	1.7M
+Net Income	142.0M	454.0M	370.0M	247.0M	-46.3M
Net Margin %	7.1%	21.4%	21.0%	17.1%	-4.0%
Net Income Attributable	142.0M	454.0M	370.0M	247.0M	-46.3M
Eps Basic	0.33	1.06	0.86	0.62	-0.12
Eps Diluted	0.33	1.05	0.86	0.62	-0.12

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.6B	1.8B	1.3B	1.3B	544.0M
Trading Financial Assets	438.0M	51.4M	419.0M	145.0M	355.0M
Accounts Receivable	212.0M	174.0M	199.0M	208.0M	246.0M
Notes Receivable	7.7M	--	1.4M	1.7M	1.8M
Notes And Accounts Receivable	220.0M	174.0M	200.0M	210.0M	248.0M
Prepayments	36.3M	55.3M	12.0M	17.2M	15.5M
Inventory	653.0M	531.0M	514.0M	441.0M	311.0M
Total Current Assets	3.0B	2.6B	2.5B	2.1B	1.5B
Fixed Assets	--	420.0M	376.0M	70.4M	68.1M
Fixed Assets Total	493.0M	420.0M	376.0M	70.4M	68.1M
Construction In Progress	--	254.0M	181.0M	373.0M	255.0M
Construction In Progress Total	394.0M	254.0M	181.0M	373.0M	255.0M
Intangible Assets	156.0M	165.0M	169.0M	179.0M	177.0M
Long Term Deferred Expenses	35.1M	17.9M	13.7M	4.7M	7.8M
Total Non Current Assets	1.3B	1.1B	1.0B	888.0M	761.0M
Total Assets	4.3B	3.8B	3.5B	3.0B	2.3B
Short Term Borrowings	262.0M	23.6M	181.0M	28.5M	384.0M
Accounts Payable	332.0M	186.0M	230.0M	230.0M	119.0M
Advance Receipts	--	--	--	--	--
Contract Liabilities	151.0M	44.6M	100.0M	52.3M	52.4M
Total Current Liabilities	1.1B	569.0M	749.0M	556.0M	828.0M
Long Term Borrowings	40.0M	--	--	43.3M	43.2M
Total Non Current Liabilities	121.0M	56.8M	55.0M	109.0M	79.1M
Total Liabilities	1.2B	625.0M	804.0M	665.0M	907.0M
Paid In Capital	433.0M	431.0M	428.0M	430.0M	404.0M
Capital Reserve	1.1B	1.1B	1.0B	1.0B	298.0M
Surplus Reserve	224.0M	204.0M	154.0M	118.0M	93.8M
Retained Earnings	1.4B	1.4B	1.1B	821.0M	598.0M
Minority Equity	--	--	--	--	--
Equity Attributable	3.1B	3.1B	2.7B	2.4B	1.3B
Total Equity	3.1B	3.1B	2.7B	2.4B	1.3B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	2.3B	2.2B	2.0B	1.6B	1.4B
Tax Refunds Received	177.0M	132.0M	134.0M	97.0M	98.9M
Total Operating Cash Inflow	2.5B	2.4B	2.1B	1.7B	1.5B
Cash Paid For Goods	907.0M	804.0M	674.0M	587.0M	471.0M
Cash Paid To Employees	850.0M	721.0M	633.0M	529.0M	499.0M
Taxes Paid	146.0M	152.0M	136.0M	105.0M	88.3M
Total Operating Cash Outflow	2.2B	1.9B	1.7B	1.4B	1.2B
Operating Cash Flow	307.0M	489.0M	473.0M	303.0M	271.0M
Total Investing Cash Inflow	1.0B	592.0M	999.0M	943.0M	2.1B
Total Investing Cash Outflow	1.6B	406.0M	1.4B	871.0M	1.9B
Investing Cash Flow	-591.0M	186.0M	-434.0M	71.5M	208.0M
Cash From Borrowings	412.0M	73.6M	222.0M	28.7M	552.0M
Dividends And Interest Paid	144.0M	82.7M	57.8M	5.5M	30.6M
Debt Repayments	134.0M	231.0M	116.0M	382.0M	578.0M
Total Financing Cash Inflow	443.0M	117.0M	222.0M	801.0M	562.0M
Total Financing Cash Outflow	361.0M	392.0M	218.0M	443.0M	639.0M
Financing Cash Flow	82.2M	-276.0M	3.8M	357.0M	-76.6M
Net Change In Cash	-203.0M	403.0M	54.4M	724.0M	390.0M
Ending Cash Balance	1.5B	1.7B	1.3B	1.3B	544.0M
Capex	207.0M	177.0M	190.0M	152.0M	155.0M